LATEST ALERTS
Companies
With appeals rejected, selected companies can produce medical cannabis…
9th May 2024 - Alerts | Central America, Panama |
Health Canada report finds high fees preventing cannabis business profits…
25th August 2023 - Alerts | Canada, North America |
Court OKs Organigram’s judicial review of Health Canada decision on Jolts…
16th August 2023 - Alerts | Canada, North America |
Law enacted allowing cannabis businesses to claim tax deductions…
28th July 2023 - Alerts | Maine, North America, United States |
Budget law gives state-level tax relief to cannabis businesses…
15th June 2023 - Alerts | Connecticut, North America, United States |
Budget bill to help cannabis businesses get tax deductions at state level…
15th June 2023 - Alerts | Illinois, North America, United States |
Claim Act reintroduced to protect against federal penalities…
28th April 2023 - Alerts | North America, United States |
Curaleaf fights against regulator’s ‘arbitrary’ non-renewal of its licences…
17th April 2023 - Alerts | New Jersey, North America, United States |
Interstate cannabis company trade bill passes state Congress…
17th April 2023 - Alerts | North America, United States, Washington |
Survey says Canadian cannabis companies lack consumer awareness
19th May 2022 - News analysis |
Canadian cannabis companies are about as well-liked as some of the country’s biggest oil refiners and transporters – a strange position for purveyors of one of the most mellow products on the market
New studies explore how cannabis can help improve women’s menstrual health
12th May 2022 - News analysis |
Clinical trials are investigating how CBD can improve menstrual health and treat conditions such as premenstrual syndrome (PMS) and perhaps even endometriosis
Canadian cannabis firms Hexo and Tilray announce new ‘strategic alliance’
10th May 2022 - News analysis |
Two major Canadian cannabis producers, Hexo and Tilray Brands, have agreed to form a “strategic alliance”, which involves Tilray acquiring Hexo’s debt in exchange for the right to purchase Hexo shares
Aurora expands recreational cannabis portfolio with Thrive acquisition
9th May 2022 - News analysis |
Canadian firm Aurora Cannabis is expanding its recreational portfolio with the acquisition of Ontario-based premium cannabis producer Thrive for CAD38m ($29) in cash and Aurora shares
Kanabo acquires The GP Service in a bid to ‘bring cannabis to the UK mainstream’
3rd May 2022 - News analysis |
Medicinal cannabis company Kanabo has bought private telemedicine platform The GP Service in a £14m deal to make its products – and those of rival companies – more accessible in the UK
Optimism blooming as Uruguay’s first medical cannabis harvest begins
25th April 2022 - News analysis |
Yvy Life Sciences, the first company authorised to grow medical-grade cannabis plants in Uruguay, has started harvesting its first crops for this purpose
Cannabis vape innovator opens online outlet to reach CBD wellness market
21st April 2022 - News analysis |
Kanabo, the company behind the UK’s first medicinal cannabis vape, has launched an e-commerce platform to sell its VapePod products to wellness CBD consumers
E-commerce platform Shopify accused of shutting down legal delta-8 THC sales
19th April 2022 - News analysis |
US-based CBD shops that used Shopify to support online sales are still dealing with the fallout weeks after the e-commerce platform suddenly removed sites it deemed non-compliant
Green energy firm plans cannabis plant on Isle of Man, avoiding UK restrictions
14th April 2022 - News analysis |
UK clean energy specialist Peel NRE has announced ambitious plans to set up a production facility for medicinal cannabis on the Isle of Man with the aim of exporting products to emerging markets beyond Europe
Tobacco giant BAT increases its stake in cannabis with more cash for Organigram
13th April 2022 - News analysis |
British American Tobacco (BAT) has invested a further CAD6.3m (USD5.03m) in the Canadian cannabis company Organigram, thereby increasing its stake from 18.8% to 19.5%
UK broadcaster Channel 4 puts its weight behind Cannaray and the CBD market
12th April 2022 - News analysis |
UK public service TV network Channel 4 believes the country’s CBD market will continue to grow and has backed its position by investing in the Cannaray brand
Medical cannabis company receives government grant…
8th April 2022 - Alerts | Australasia, New Zealand |
New cannabis-infused drink combines an energy boost with getting high
1st April 2022 - News analysis |
A new cannabis-infused energy drink targets consumers who want to combine their workouts with getting high
Aardachtig part of Closed Coffeeshop Chain Experiment…
14th March 2022 - Alerts | Europe, Netherlands |
Could the Pfizer acquisition of Arena be a sign of things to come in Big Pharma?
4th March 2022 - News analysis |
While Big Pharma acquisitions of companies involved in the development of cannabinoid treatments are expected to to propel and expand cannabinoid treatment options, the overall impact of and interest in Big Pharma’s reach into the industry remains a matter of speculation
‘A major step forward’ for CBD as EC validates a few novel food applications
2nd March 2022 - News analysis |
The European Food Safety Authority (EFSA) has validated the novel food applications of at least five CBD producers, marking what one company called an “important milestone” in the ongoing saga of EU CBD regulation
Only in California: the fresh vape that’s cannabis and nothing but the cannabis
9th February 2022 - Blogs , News analysis |
The latest offering from the company that first devised the Juul e-cigarette looks sure to be a new Californian craze – a new vaping pod “made solely from pure cannabis”
German pharma firm buys €80m C3 to boost its European cannabis presence
26th January 2022 - News analysis |
German pharmaceutical manufacturer Dermapharm Holding is paying Canadian cannabis giant Canopy Growth €80m for the Cannabinoid Compound Company (C3)
Native Americans can help Audacious bid for jump start on NY recreational licence
24th January 2022 - News analysis |
Audacious Brands is the latest cannabis company to look at a partnership with a Native American tribe to gain a head start in the New York recreational cannabis market
CBD’s popularity sparks gold rush to develop rare cannabinoids
19th January 2022 - News analysis |
Potential demand for rarer cannabinoids is prompting firms to explore other methods of manufacturing, such as biosynthesis and chemical synthesis, to give higher yields at lower cost
Hemp and CBD expansion in Thailand continues with government help
5th January 2022 - News analysis |
Government support of Thailand’s hemp and CBD industry is paying off. Examples include US based Australis’ partnership with local GTH and MPX International’s agreement with Salus Thailand
British Cannabis to manufacture Elixinol for UK and EU after slip-up on novel food
28th December 2021 - News analysis |
Elixinol will continue to be produced for the UK under a licensing agreement with British Cannabis despite having pulled out of the UK and European markets after missing the boat on novel food applications
So it’s farewell to 2021 – a year that promised little and delivered less
27th December 2021 - News analysis |
If 2020 was the year in the waiting-room then 2021 was perhaps the year of the unfulfilled hype. As predicted, there was little movement in many of the major issues controlling the CBD market
Omura to take its heated Flowersticks international, starting in Switzerland
21st December 2021 - News analysis |
The US-based heat-not-burn (HnB) hemp company Omura will announce a new set of target country markets in the first quarter of 2022, starting with Switzerland as a bridge into Europe
Cannabis companies go on acquisition spree for US stores and tech companies
15th December 2021 - News analysis |
Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech companies
UK health trust teams up with Awakn to investigate psychedelic treatment
13th December 2021 - News analysis |
The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment
Growing investor interest sparks more funding for psychedelic clinical trials
10th December 2021 - News analysis |
The potential of psychedelics to treat a range of mental health conditions continues to attract increasing levels of funding for clinical trials as firms work towards bringing them into mainstream medical use
Multi-million, multi-state M&A deals as cannabis dispensaries spread across US
17th November 2021 - News analysis |
As the market for medical cannabis goes on growing, dispensaries continue to drive merger and acquisition activity in the US as multi-state operators invest millions of dollars in expanding their retail footprint
Couche-Tard tipped for a big future in US CBD retail through its Circle K stores
11th November 2021 - News analysis |
It owns one of North America’s biggest chains of convenience stores and fuel stations – now Alimentation Couche-Tard may have the potential to become one of its foremost providers of cannabis and CBD
Secondary concerns a growth area as US firms buy into cannabis industry services
26th October 2021 - News analysis |
The economic tide flowing for cannabis continues to float businesses in the US in secondary areas such as cultivation systems and delivery services too
Canadian firm Flora Growth picks Colombia for its cannabis production
22nd October 2021 - News analysis |
Toronto-based Flora Growth believes increasing legalisation will eventually lead to cannabis becoming a commodity much like any other crop, and has chosen to focus much of its cannabis production in Colombia
Brazilian report highlights theoretical growth but small current numbers
22nd October 2021 - News analysis |
Interest in the Brazilian medical cannabinoid market is based on optimistic projections of growth continuing in the same vein rather than concrete current numbers, a domestic report has confirmed
Cannabis dispensaries tempt investors into multimillion US acquisitions
21st October 2021 - News analysis |
US cannabis dispensaries are attracting significant interest from investors and several multi-million dollar deals have been agreed as operators expand their footprint into new states
CBD suppliers to US risk being shut out by online credit card processors
20th October 2021 - News analysis |
Ambiguous messages about where CBD companies will ship to in the USA may result in risk-averse online payments processors refusing to deal with them, says a speakers at the upcoming USA-CBD Expo in Chicago
UK advertising watchdog raps shopping channel over CBD firm’s health claims
18th October 2021 - News analysis |
The UK Advertising Standards Authority (ASA) has held a shopping infomercial channel to account for claims made for a CBD product being marketed during one of its shows
Potential for psychedelic treatments prompts big North American buyouts
15th October 2021 - News analysis |
Interest in psychedelic drugs and treatments continues to grow, as evidenced by three major takeovers in Canada and the USA, two involving drug treatments developments and another offering a network of ketamine infusion treatment centres
